TSW
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.57B
Turnover
15.37%
1-Year Est. Return
9.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+9.46%
3 Year Est. Return
+32.41%
5 Year Est. Return
+38.31%
10 Year Est. Return
+103.24%
AUM
$7.3B
AUM Growth
+$297M
(+4.2%)
Cap. Flow
-$50.3M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
17.43%
Holding
817
New
58
Increased
143
Reduced
218
Closed
72
Avg Time Held
3.7
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$86.7M |
| 2 |
Graphic Packaging
GPK
|
+$49.8M |
| 3 |
Flex
FLEX
|
+$46.9M |
| 4 |
Old Republic International
ORI
|
+$46M |
| 5 |
NVR
NVR
|
+$40.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$92.1M |
| 2 |
Bunge Global
BG
|
+$50.3M |
| 3 |
Leidos
LDOS
|
+$39.3M |
| 4 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$38.5M |
| 5 |
NCR Voyix
VYX
|
+$34.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.68% |
| 2 | Technology | 12.25% |
| 3 | Healthcare | 9.96% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Utilities | 9.65% |
Similar funds
HIP
VAM
CBUSF
LP
AFI
IA
BCL
GAM
Thompson Siegel & Walmsley's Q2 2021 Portfolio in Review
As of Q2 2021, Thompson Siegel & Walmsley held 817 positions worth $7.3B, up 4.2% from $7.01B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Thompson Siegel & Walmsley's Q2 2021 filing shows 58 new, 143 increased, 218 reduced and 72 closed positions. Its largest new stake was Organon & Co: 2,634,306 shares worth $79.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Thompson Siegel & Walmsley's largest Q2 2021 buy was Organon & Co: 2,634,306 shares worth $79.7M.
- Thompson Siegel & Walmsley added most to Graphic Packaging in Q2 2021, an estimated $49.8M increase.
- Thompson Siegel & Walmsley's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $92.1M.
- Thompson Siegel & Walmsley fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $38.5M.
- Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $7.3B portfolio in Q2 2021.
- Thompson Siegel & Walmsley opened 58 new positions and closed 72 in Q2 2021.
- Thompson Siegel & Walmsley's portfolio value rose 4.2% quarter-over-quarter to $7.3B.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.